• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部切除直肠癌患者行全直肠系膜切除的评估:谨慎之语。

Evaluation of a Completion Total Mesorectal Excision in Patients After Local Excision of Rectal Cancer: A Word of Caution.

出版信息

J Natl Compr Canc Netw. 2018 Jul;16(7):822-828. doi: 10.6004/jnccn.2018.7026.

DOI:10.6004/jnccn.2018.7026
PMID:30006424
Abstract

According to Dutch guidelines, locally excised, low-risk, pT1 or ypT0-1 rectal cancer should not necessarily be followed by completion total mesorectal excision (cTME) in contrast to rectal cancers with higher T stages or unfavorable features. This study evaluated cTME after local excision at a national level with possible determinants for decision-making. All patients in the Dutch Colorectal Audit (DCRA) who underwent local excision of rectal cancer between 2012 and 2015 were included. Guideline adherence for performing cTME was determined with univariate and multivariate analyses to identify factors related to noncompliance. According to the guidelines, of 530 included patients, cTME was indicated in 283 (53%), and among those, was performed in 82 (29%). Guideline adherence for performing cTME improved significantly (<.001), from 10% in 2012 to 44% in 2015. Lower Charlson comorbidity index in patients with high-risk pT1 rectal cancer and younger patients (aged 61-70 years vs ≥80 years) with pT≥2 rectal cancer were associated with increased performance of cTME (odds ratio [OR], 13.50; 95% CI, 1.39-131.32, and OR, 6.25; 95% CI, 1.83-21.31, respectively). In this population-based study from the Netherlands, only a minority of patients underwent cTME after local excision of rectal cancer with pathologic features indicating the need for further treatment according to the guidelines. Although the percentage of patients undergoing cTME increased over time, the study indicated a tendency toward rectal-preserving treatment with potential oncologic risks.

摘要

根据荷兰指南,与 T 分期更高或具有不良特征的直肠癌相比,局部切除、低危、pT1 或 ypT0-1 直肠肿瘤不一定需要进行补充全直肠系膜切除术(cTME)。本研究在全国范围内评估了局部切除后行 cTME 的情况,并分析了决策的可能决定因素。荷兰结直肠审计(DCRA)纳入了 2012 年至 2015 年间接受局部切除直肠癌的所有患者。通过单变量和多变量分析确定了进行 cTME 的指南依从性,以确定与不遵守相关的因素。根据指南,530 例纳入患者中,283 例(53%)需要行 cTME,其中 82 例(29%)进行了 cTME。行 cTME 的指南依从性显著提高(<.001),从 2012 年的 10%增加到 2015 年的 44%。高危 pT1 直肠肿瘤和 pT≥2 直肠肿瘤中年龄较大(61-70 岁 vs ≥80 岁)患者的 Charlson 合并症指数较低,与 cTME 实施率增加相关(比值比 [OR],13.50;95%CI,1.39-131.32 和 OR,6.25;95%CI,1.83-21.31)。在这项来自荷兰的基于人群的研究中,仅有少数患者接受了局部切除后的 cTME,尽管这些患者具有根据指南需要进一步治疗的病理特征。尽管随着时间的推移,行 cTME 的患者比例有所增加,但该研究表明了一种倾向于保留直肠的治疗方法,可能存在潜在的肿瘤学风险。

相似文献

1
Evaluation of a Completion Total Mesorectal Excision in Patients After Local Excision of Rectal Cancer: A Word of Caution.局部切除直肠癌患者行全直肠系膜切除的评估:谨慎之语。
J Natl Compr Canc Netw. 2018 Jul;16(7):822-828. doi: 10.6004/jnccn.2018.7026.
2
Short-term outcomes of transanal completion total mesorectal excision (cTaTME) for rectal cancer: a case-matched analysis.经肛门全直肠系膜切除(cTaTME)治疗直肠癌的短期疗效:病例匹配分析。
Surg Endosc. 2019 Jan;33(1):103-109. doi: 10.1007/s00464-018-6280-3. Epub 2018 Jul 2.
3
Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment.局部切除早期直肠癌后的局部复发:全直肠系膜切除术、辅助(放)化疗或不追加治疗的荟萃分析。
Br J Surg. 2020 Dec;107(13):1719-1730. doi: 10.1002/bjs.12040. Epub 2020 Sep 16.
4
The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.根治性全直肠系膜切除术中局部进展期直肠癌的放化疗对复发和生存的影响:一项前瞻性、非随机研究。
World J Surg Oncol. 2017 Nov 22;15(1):205. doi: 10.1186/s12957-017-1275-4.
5
Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.使用新辅助放化疗和局部切除对临床T2N0期低位直肠癌进行器官保留(ACOSOG Z6041):一项开放标签、单臂、多机构的2期试验结果
Lancet Oncol. 2015 Nov;16(15):1537-1546. doi: 10.1016/S1470-2045(15)00215-6. Epub 2015 Oct 22.
6
Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer.直肠癌新辅助放化疗后完成全直肠系膜切除术和局部切除术。
Colorectal Dis. 2024 Feb;26(2):281-289. doi: 10.1111/codi.16834. Epub 2023 Dec 22.
7
Local excision vs. proctectomy in patients with ypT0-1 rectal cancer following neoadjuvant therapy: a propensity score matched analysis of the National Cancer Database.新辅助治疗后 ypT0-1 期直肠腺癌患者行局部切除与直肠切除术的比较:基于国家癌症数据库的倾向评分匹配分析。
Tech Coloproctol. 2024 Sep 21;28(1):128. doi: 10.1007/s10151-024-02994-4.
8
Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.直肠癌的放化疗联合局部切除保肛治疗:GRECCAR 2 随机试验的 5 年结果。
Lancet Gastroenterol Hepatol. 2020 May;5(5):465-474. doi: 10.1016/S2468-1253(19)30410-8. Epub 2020 Feb 7.
9
Local excision following chemoradiotherapy in T2-T3 rectal cancer: current status and critical appraisal.局部切除联合放化疗治疗 T2-T3 期直肠癌:现状与评价。
Updates Surg. 2020 Mar;72(1):29-37. doi: 10.1007/s13304-019-00689-2. Epub 2019 Oct 16.
10
Local excision in rectal cancer patients with major or complete clinical response after neoadjuvant therapy: a case-matched study.新辅助治疗后主要或完全临床缓解的直肠癌患者的局部切除:一项病例匹配研究。
Int J Colorectal Dis. 2019 Dec;34(12):2129-2136. doi: 10.1007/s00384-019-03420-0. Epub 2019 Nov 14.

引用本文的文献

1
Short-term outcomes after primary total mesorectal excision (TME) versus local excision followed by completion TME for early rectal cancer: population-based propensity-matched study.直肠癌患者行直肠系膜全切除(TME)与局部切除后补救性 TME 的短期疗效比较:基于人群的倾向性匹配研究
BJS Open. 2024 Sep 3;8(5). doi: 10.1093/bjsopen/zrae103.
2
Short- and long-term outcomes in ypT2 rectal cancer patients after neoadjuvant therapy and local excision: a multicentre observational study.新辅助治疗和局部切除后 ypT2 直肠肿瘤患者的短期和长期预后:一项多中心观察性研究。
Tech Coloproctol. 2023 Jan;27(1):53-61. doi: 10.1007/s10151-022-02712-y. Epub 2022 Oct 14.
3
Long-term oncological outcomes after local excision of T1 rectal cancer.
T1 期直肠肿瘤经局部切除后的长期肿瘤学结果。
Tech Coloproctol. 2023 Jan;27(1):23-33. doi: 10.1007/s10151-022-02661-6. Epub 2022 Aug 27.
4
Prognosis of Patients Over 60 Years Old With Early Rectal Cancer Undergoing Transanal Endoscopic Microsurgery - A Single-Center Experience.60岁以上早期直肠癌患者行经肛门内镜微创手术的预后——单中心经验
Front Oncol. 2022 Jun 14;12:888739. doi: 10.3389/fonc.2022.888739. eCollection 2022.
5
Risk of recurrence after local resection of T1 rectal cancer: a meta-analysis with meta-regression.T1 期直肠癌局部切除术后复发风险:荟萃分析与荟萃回归。
Surg Endosc. 2022 Dec;36(12):9156-9168. doi: 10.1007/s00464-022-09396-3. Epub 2022 Jun 30.
6
An endorectal ultrasound-based radiomics signature for preoperative prediction of lymphovascular invasion of rectal cancer.基于直肠内超声的放射组学特征术前预测直肠癌的血管淋巴管侵犯。
BMC Med Imaging. 2022 May 10;22(1):84. doi: 10.1186/s12880-022-00813-6.
7
Implementation of transanal minimally invasive surgery (TAMIS) for rectal neoplasms: results from a single centre.经肛门微创外科(TAMIS)治疗直肠肿瘤的实施:单中心研究结果。
Tech Coloproctol. 2022 Mar;26(3):175-180. doi: 10.1007/s10151-021-02556-y. Epub 2021 Dec 14.
8
Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment.局部切除早期直肠癌后的局部复发:全直肠系膜切除术、辅助(放)化疗或不追加治疗的荟萃分析。
Br J Surg. 2020 Dec;107(13):1719-1730. doi: 10.1002/bjs.12040. Epub 2020 Sep 16.